• Over 15 years of experience as a financial analyst of public and private life science companies.

• Significant expertise in fund operations, taxation, accounting and trading.

 

Prior to joining the firm full-time in 2008, Mr. David Fischel was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel also serves as CEO and Chairman of the Board of Directors of Stereotaxis Inc, a publicly traded medical technology company.

 

Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar Ilan University in Tel Aviv, Israel. He is a Certified Public Accountant, Chartered Financial Analyst, and Chartered Alternative Investment Analyst.

​

Click here to view Mr. Fischel's complete resume.